Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Benitec Biopharma Inc.

NASDAQ: BNTC · Life Sciences · 7 alerts · CIK 1808898

Share price
$8.54Close, Nov 16
Market cap
$298M
Shares outstanding
34.88MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Benitec Biopharma Inc. filings on SEC EDGAR ↗

8:03 AM ET 8-K
Clinical Trial Data

Benitec Biopharma Clinical Trial Data

Benitec Biopharma announced positive interim Phase 1b/2a results for its gene therapy BB-301 in patients with Oculopharyngeal Muscular Dystrophy (OPMD). The data showed a 100% responder rate across both low and high dose cohorts, with the high dose group demonstrating greater relative improvements in throat emptying and swallowing capacity at the 3-month mark.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.